UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.663-667

2016

Volltextzugriff (PDF)

Biopsy-Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

American journal of transplantation, 2010-09, Vol.10 (9), p.2017-2025

2010

Volltextzugriff (PDF)

Genetic characterization of acquired aplastic anemia by targeted sequencing

Haematologica (Roma), 2014-09, Vol.99 (9), p.e165

2014

Volltextzugriff (PDF)

Hepatitis E virus infection in a hematopoietic stem cell donor

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.159-160

2014

Volltextzugriff (PDF)

SETBP1 mutation analysis in 944 patients with MDS and AML

Leukemia, 2013-10, Vol.27 (10), p.2072-2075

2013

Volltextzugriff (PDF)

Biopsy‐Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

American journal of transplantation, 2010-09, Vol.10 (9), p.2017-2025

2010

Volltextzugriff (PDF)

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Leukemia, 2014-07, Vol.28 (7), p.1552-1555

2014

Volltextzugriff (PDF)

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1519-1525

2017

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

American journal of transplantation, 2015-03, Vol.15 (3), p.705-714

2015

Volltextzugriff (PDF)

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

Leukemia, 2015-09, Vol.29 (9), p.1942-1945

2015

Volltextzugriff (PDF)

OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Solid Organ Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Multicenter Study of the EBMT

American journal of transplantation, 2010-08, Vol.10 (8), p.1897-1906

2010

Volltextzugriff (PDF)

P1444: IMPACT OF CO‐MORBIDITIES ON NON‐RELAPSE MORTALITY AND CYTOKINE‐RELEASE SYNDROME AFTER CD19 CAR‐T CELL THERAPY ‐ A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION

HemaSphere, 2022-06, Vol.6 (Suppl), p.1327-1328

2022

Volltextzugriff (PDF)

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM‐4 STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.830-831

2022

Volltextzugriff (PDF)

Low frequency of calreticulin mutations in MDS patients

Leukemia, 2014-09, Vol.28 (9), p.1933-1934

2014

Volltextzugriff (PDF)

Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?

Transplant infectious disease, 2012-02, Vol.14 (1), p.103-106

2012

Volltextzugriff (PDF)

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Blood, 2022-07, Vol.140 (4), p.349-358

2022

Volltextzugriff (PDF)

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1259-1261

2016

Volltextzugriff (PDF)

133 UNRELATED CORD BLOOD OR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS RECEIVING A REDUCED INTENSITY CONDITIONING REGIMEN: AN EBMT STUDY

Leukemia research, 2015-04, Vol.39, p.S68-S68

2015

Volltextzugriff (PDF)

O-003 ASXL1 frameshift mutations in patients with MDS and AML following MDS after allogeneic SCT: Update on 206 patients

Leukemia research, 2013-05, Vol.37, p.S10-S10

2013

Volltextzugriff (PDF)

1255 CHRONIC HEPATITIS E IN IMMUNOSUPPRESSED PATIENTS BEYOND LIVER- AND KIDNEY TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S495-S495

2011

Volltextzugriff (PDF)

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Leukemia, 2024-05, Vol.38 (5), p.1156-1163

2024

Volltextzugriff (PDF)

P-114 SETBP1 mutations in MDS and sAML

Leukemia research, 2013-05, Vol.37, p.S75-S75

2013

Volltextzugriff (PDF)

P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation

Leukemia research, 2013-05, Vol.37, p.S118-S119

2013

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(27)
Hematology
(22)
Male
(17)
Transplantation
(17)
Adult
(16)
Oncology
(16)
Stem Cell Transplantation
(16)
Female
(15)
Middle Aged
(15)
Aged
(11)
Immunology
(11)
Medicin Och Hälsovetenskap
(11)
Retrospective Studies
(10)
Biophysics
(9)
Hematopoietic Stem Cell Transplantation
(9)
Adolescent
(8)
Biological And Medical Sciences
(8)
Bone Marrow
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

Biopsy-Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

Genetic characterization of acquired aplastic anemia by targeted sequencing

Hepatitis E virus infection in a hematopoietic stem cell donor

SETBP1 mutation analysis in 944 patients with MDS and AML

Biopsy‐Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS

Solid Organ Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Multicenter Study of the EBMT

P1444: IMPACT OF CO‐MORBIDITIES ON NON‐RELAPSE MORTALITY AND CYTOKINE‐RELEASE SYNDROME AFTER CD19 CAR‐T CELL THERAPY ‐ A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM‐4 STUDY

Low frequency of calreticulin mutations in MDS patients

Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

133 UNRELATED CORD BLOOD OR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS RECEIVING A REDUCED INTENSITY CONDITIONING REGIMEN: AN EBMT STUDY

O-003 ASXL1 frameshift mutations in patients with MDS and AML following MDS after allogeneic SCT: Update on 206 patients

1255 CHRONIC HEPATITIS E IN IMMUNOSUPPRESSED PATIENTS BEYOND LIVER- AND KIDNEY TRANSPLANTATION

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

P-114 SETBP1 mutations in MDS and sAML

P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern